baber/WOPTO huggingface dataset:
Patent DK-352486-D0 (DK)
Inventor: SHROOT BRAHAM
IPC: C07D311/92
Filed: 1986-07-24
Abstract: The compounds in question correspond to the following general formula: <IMAGE>  in which: X represents -CH=CH-, O or S, R1 and R2, which may be identical or different, represent a hydrogen atom, a linear or branched alkyl radical having from 1 to 15 carbon atoms or an alkoxy radical having from 1 to 6 carbon atoms, or R1 and R2, taken together and with the adjacent carbon atoms of the naphthalene ring-system, form a 5- or 6-membered ring optionally substituted with at least one lower alkyl radical or interrupted by an oxygen atom, and R3 represents a -CH2OH radical or a radical -COR4, or alternatively a -CH3 radical in the case where R1 and R2, taken together form a 5- or 6-membered ring,  R4 representing -OR5 or <IMAGE> R5 representing a hydrogen atom, an alkyl radical having 1 to 20 carbon atoms, monohydroxyalkyl, polyhydroxyalkyl, aryl or aralkyl radical, optionally substituted, or a sugar residue, or alternatively represents a radical: <IMAGE> p being 1, 2 or 3, r' and r'' representing a hydrogen atom, a lower alkyl radical, a monohydroxyalkyl or polyhydroxyalkyl radical, an optionally substituted aryl radical or an amino acid residue or amino sugar residue, or alternatively, taken together, form a heterocycle, including the salts of the derivatives of formula (I).
Patent DK-461388-D0 (DK)
Inventor: SCHLOEMER GEORGE C
IPC: C07C303/30
Filed: 1988-08-17
Abstract: Pharmaceutically useful optically active  alpha -arylalkanoic acids of the formula <CHEM> where Ar is aryl and R1 is alkyl or cycloalkyl or esters, ortho esters, or amides thereof are stereoselectively prepared by contacting a reagent of the formula Ar-MX, (Ar) 2M or ArM' where M is Cd, Cu(II), Mn(II), Mg or Zn, and M' is Cu(I) or Li, and X is halogen, with an optically active compound of the formula <CHEM>  where Z is a leaving group and Y is halogen, acyloxy or <CHEM> where R' and R'' are alkyl, aryl or with N are a heterocyclic group, to form the optically active ketone of the formula <CHEM> which is ketalized and rearranged to said acid, ester, ortho ester or amide. Alternatively, said ketone is reduced to the corresponding alkanol, which is rearranged to the  alpha -arylalkanal. The alkanal so produced is converted to said acid by conventional methods.
Patent DK-533785-D0 (DK)
Inventor: CIAUDELLI JOSEPH P
IPC: C07C69/675
Filed: 1985-11-19
Abstract: The present invention relates to a fatty acid ester of the formula
 CH3(CH2)5CH(OCOR1)(CH2)10COOR2
 wherein,
 R1 is a hydrocarbon radical having 17 carbon atoms with 1 to 3 double bonds therein; and
 R2 is a hydrocarbon radical having 5 to 22 carbon atoms.
Patent DK-540186-D0 (DK)
Inventor: DIEN RENE
IPC: C08F222/40
Filed: 1986-11-12
Abstract: Novel, heat-stable imido polymers, well adopted, e.g., as impregnants, or coating or molding resins, comprise the polymerizates of (a) at least one N,N'-bismaleimide, (b) at least one alkenyloxyaniline, and, optionally, (c) at least one N-(meth)allyloxyphenylmaleimide.
Patent DK-569089-D0 (DK)
Inventor: ANDERSSON BO
IPC: F16K31/40
Filed: 1989-11-14
Abstract: Valve for pressurized media which includes a valve housing provided with inlet and outlet and a movable main valve plug for infinitely variably controlling the pressurized medium flow through the valve with the aid of a pilot flow originating from the pressurized medium flow and passing through a variable throttling means situated in the main valve plug. For obtaining a compact valve unit, the pilot flow control valve (18) is arranged in a member arranged as a lid on a cartridge sleeve including the valve housing, for opening or closing a pilot flow duct (15) in the cartridge in response to a control signal, a pressure compensation means (54) being arranged in the duct (15) after the throttling means (26) in the main valve plug (5) but before the pilot flow control valve (18), this means (54) being under the action of the pressure in the pilot flow duct (15) prevailing after the throttling means (26) and of a piston sensing the pressure in the valve inlet and/or outlet for throttling or interrupting the pilot flow before the pilot flow control valve (18) in response to pressure changes in the inlet or outlet.
Patent DK-569687-D0 (DK)
Inventor: SAUERBIER DIETER
IPC: A61K31/675
Filed: 1987-10-30
Abstract: 1. A lyophilized preparation consisting of ifosfamide and 0.1 to 17 parts by weight hexitol per part by weight ifosfamide and, optionally, other standard pharmaceutical auxiliaries.
Patent HU-903767-D0 (HU)
Title: Process for producing new 4-/4-/4-/4-//2-(2,4 difluor-phenyl)-2-(1h-azolyl-methyl)- -1,3 dioxolane-4-il/methoxy/-phenyl/-1-derivatives and pharmaceutical preparatives containing such compounds
Inventor: HEERES JAN
IPC: A61K31/4166
Filed: 1990-06-08
Abstract: 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4 -yl]methoxy]pheny l ]-1-piperazinyl]phenyl]triazolones and imidazolones of formula <CHEM>  wherein  Q is CH or N;  Y is a radical of formula <CHEM> R<1> is C5-7cycloalkyl or mono-, di-, tri-, tetra- or pentahaloC1-4alkyl; and R<2> is C1-6alkyl, C5-7cycloalkyl or mono-, di-, tri-, tetra- or pentahaloC1-4alkyl, the acid addition salts and stereoisomeric forms thereof; said compounds having antifungal properties. Pharmaceutical compositions containing such compounds as an active ingredient; methods of preparing said compounds and pharmaceutical compositions.
Patent NO-862193-D0 (NO)
Inventor: FORSSEN ERIC
IPC: A61K9/08
Filed: 1986-06-03
Abstract: Anthracycline anti-neoplastic agents are formulated in phospholipid micellular particles. In a preferred embodiment, the particles are in the form of vesicles which comprise an anthracycline agent, preferably daunorubicin, distearyl phosphatidyl choline, distearyl phosphatidyl glycerol and cholesterol, preferably in a molar ratio of about 1:2:0:0 to about 1:4:20:20. The vesicles are suspended in a low ionic solution such as 5% dextrose at pH 7.4.
Patent NO-873152-D0 (NO)
Inventor: FELBER JOSEF
IPC: E04H6/44
Filed: 1987-07-28
Abstract: A weather protective roofing structure for small aircraft comprising a plurality of hemispherical bars which are supported in a rotatable manner around a common axis, which bars are attached to and covered with a plurality of covering material segments forming a hemispherical cover. The hemispherical bars are rotatable around the common axis by means of a tackle apparatus and an electrical winch during assembly of the roofing structure to form an enclosure, and during disassembly and folding of the hemispherical cover. Assembly and disassembly are facilitated by means of two torsion springs provided at the hinge assemblies and attached to the outermost bar.
Patent NO-884163-D0 (NO)
Inventor: GASBJERG KNUD
IPC: A01J25/11
Filed: 1988-09-20
Abstract: With the use of a distributor unit (4, 8), which is reciprocable over and along an oblong prepressing vat for cheese production, it has already been proposed that a uniform distribution of the whey/coagulum mixture can be achieved by means of horizontal wing rotors in a transverse distributor container (8), such rotor or rotors being rotated to lift the mixture up to an overflowing edge of the container while isolating the mixture from the turbulent mixture receiving area of the container. However, it is experienced that coagulum lumps may build up on the overflowing edge and thus disturb an even overflow. The invention provides for two interengaging wing rotors (22) mounted at the bottom of the container (8) so as to sluice down the mixture along opposite, correspondingly arched bottom/side portions (21) to a central lowermost outlet slot (20), whereby the risk of lump formations is practically eliminated without compromizing the desired uniform distribution of the coagulum.
Patent NO-891007-D0 (NO)
Inventor: FUJII TAKERU
IPC: A61K38/095
Filed: 1989-03-09
Abstract: Pharmaceutical compositions of matter adapted for intravaginal administration comprise a biologically active polypeptide, an absorption promoter, such as an anionic and/or nonionic surfactant or a nonionic surfactant and an aliphatic carboxylic acid, optionally an animal and/or vegetable protein and a nontoxic pharmaceutically acceptable carrier or diluent therefor, in a formulation suitable for intravaginal administration. Preferred compositions comprise calcitonin as the biologically active polypeptide. Preferred absorption promoters are anionic surfactants, e.g., sodium lauryl sulfate, and the combination absorption promoter of a nonionic surfactant and a medium chain aliphatic carboxylic acid or its salt, e.g. polyoxyethylenealkylphenylether and a medium chain aliphatic carboxylic acid.
Patent NO-892302-D0 (NO)
Inventor: LOKEN MICHAEL R
IPC: G01N33/569
Filed: 1989-06-05
Abstract: A method for multi-parameter analysis of cells in a body fluid sample is described which makes use of a plurality of fluorescence measurements, comprising at least two nucleic acid dyes and at least one fluorescently labelled cell surface marker, and a plurality of light scattering measurements. A kit containing the nucleic acid dyes and cell surface marker also is described.
Patent NO-892998-D0 (NO)
Inventor: GRINTER TREVOR JOHN
IPC: C07D473/40
Filed: 1989-07-21
Abstract: A process for the preparation of a compound of formula (I) or a pharmaceutically acceptable salt thereof: <CHEM>  which process comprises reacting a compound of formula (I): <CHEM> wherein the amino group is optionally protected, Y is iodo, optionally substituted benzylthio or (phenacylmethyl)thio, with a compound of formula (III): <CHEM> wherein Q is a leaving group, Rx and Ry are protected hydroxymethyl or acyloxymethyl, or group(s) convertible to hydroxymethyl or acyloxymethyl; and Rz is hydrogen or a group convertible thereto; and thereafter converting Y to X is hydroxy by means of hydrolysis, or to X is hydrogen by means of reduction; converting Rx and Ry when other than hydroxymethyl or acyloxymethyl, to hydroxymethyl or acyloxymethyl, optionally converting Rx/Ry hydroxymethyl to acyloxymethyl or vice versa, deprotecting the 2-amino group where necessary and converting Rz, (when other than hydrogen) to hydrogen; and optionally forming a pharmaceutically acceptable salt thereof.
Patent NO-921886-D0 (NO)
Inventor: WAETJEN FRANK
IPC: A61K31/495
Filed: 1992-05-13
Abstract: New imidazoquinoxaline compounds having the general formula I <IMAGE> (I)  wherein  <IMAGE>  wherein R1 and R2 independently are hydrogen, straight or branched C1-6-alkyl, or C3-7-cycloalkyl; R3 is hydrogen, straight or branched C1-6-alkyl, straight or branched C2-6-alkenyl, or aralkyl or aroylalkyl which may optionally be substituted with halogen or C1-6-alkoxy; R4 and R5 independently are hydrogen, halogen, C1-6-alkyl or trifluoromethyl. The compounds are useful in psychopharmaceutical preparations as anticonvolusants, anxiolytics, hypnotics and in improving the cognitive function of the brain of mammals.
Patent NO-923485-D0 (NO)
Inventor: ALMEN TORSTEN
IPC: A61K47/02
Filed: 1992-09-08
Abstract: A contrast medium of aq. carrier, dissolved contrast agent and dissolved sodium cpd. providing a sodium ion concn. of 15-75 mM Na/l is characterised in that it also contains a dissolved calcium salt and opt. potassium and magnesium salts in a total concn. of up to 0.8 mM Ca/l and up to 2 mM K/l, the ratio of sodium ions to calcium ions being greater than 55. Pref. the Ca concn. is 0.05-0.7 mM Ca(2+)/l (esp. 0.1-0.6 mM Ca(2+)/l), the K concn. is 0.2-1.5 mM K(+)/l (esp. 0.3-1.2 mM K(+)/l) and the Mg concn. is up to 0.8 mM Mg(2+)/l (esp. 0.05-0.4 mM Mg(2+)/l). Pref. the contrast agent is iodinated e.g. iohexol, ioversol, iopamidol, iotrolan, ioxaglate or iodix anol.
Patent NO-944210-D0 (NO)
Inventor: HODGEN GARY D
IPC: A61K31/565
Filed: 1994-11-04
Abstract: A method for minimizing menstrual bleeding irregularities in individuals using progesting-only pharmaceutical preparations, such as contraceptives, is disclosed.
Patent NO-951459-D0 (NO)
Inventor: RASENBERG JOHANNES THEODORUS M
IPC: B60N2/42
Filed: 1995-04-18
Abstract: The invention relates to a seat, in particular for use in a vehicle, provided with a seat part, a seat back and a head support, wherein means are arranged between the seat back and the head support for supporting the neck of a user. These neck supporting means can comprise at least one pillow body protruding forward at least partially from a principal plane defined by the seat back and the head support, which pillow body can have a contour form corresponding with the neck contours of the user. The pillow body can be deformable and height-adjustable relative to the seat part. <IMAGE>
Patent NO-963031-D0 (NO)
Inventor: BECKETT RAYMOND PAUL
IPC: A61K31/40
Filed: 1996-07-19
Abstract: Matrix metalloproteinase inhibiting compounds of formula (I) <CHEM>  wherein   X   is a -CO2H or -CONHOH group; R1   is methyl, ethyl, allyl, thienylsulphanylmethyl, thienylsulphinylmethyl, or thienylsulphonylmethyl; R2   is iso-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, propylsulphanyl, cyclohexylpropyl, phenylpropyl, 4-chlorophenylpropyl, 4-methylphenylpropyl, 4-methoxyphenylpropyl, phenylbutyl, or propyloxymethyl;. R3   is a group -C(C1-C6 alkyl)2R11 wherein   R11 is -OH, -SH, -O(C1-C6)alkyl, -S(C1-C6)alkyl, -SO(C1-C6)alkyl, -SO2(C1-C6) alkyl, cyclohexylmethylsulphanyl, -OPh, -OCH2Ph, -SPh, -SOPh, -SO2Ph, -SCH2Ph, -SOCH2Ph, or -SO2CH2Ph in which any of the foregoing Ph (phenyl) groups may be substituted;   R4   is (C1-6)alkyl, (C1-C4)perfluoroalkyl or a group D-(C1-C6)alkyl- wherein D represents hydroxy, (C1-C6)alkoxy, (C1-C6)alkylsulphanyl, acylamino, optionally substituted phenyl or heteroaryl; R5   is hydrogen; or a salt, hydrate or solvate thereof.s
Patent NO-963969-D0 (NO)
Inventor: BRENTRUP LUDGER
IPC: F27B7/20
Filed: 1996-09-20
Abstract: A cement clinker prodn. plant has a raw material pretreatment stage (1), a clinker firing kiln (2), an off-gas line (3) connecting the kiln to the pretreatment stage, a clinker cooler (4) and, connected to the off-gas line (3), a reactor which produces a fuel gas from waste materials (esp. old tyres) and which is in the form of a gasifying reactor (5) connected to the cooler via a tertiary air line (6) such that at least part of the waste air from the cooler (4) can be used as gasifying medium in the reactor. The provision of a device (8) for controlling the tertiary air amount supplied by the tertiary air line to the reactor in accordance with the waste material filling height and/or the temp. in the reactor. Also claimed is a corresponding cement clinker prodn. process.
Patent NO-965095-D0 (NO)
Inventor: LAUFER STEFAN
IPC: C07D487/04
Filed: 1996-11-29
Abstract: PCT No. PCT/EP95/02079 Sec. 371 Date Mar. 28, 1997 Sec. 102(e) Date Mar. 28, 1997 PCT Filed May 31, 1995 PCT Pub. No. WO95/32972 PCT Pub. Date Dec. 7, 1995The present invention relates to heterocyclic compounds of the formula in which R1-R7, B, a and X have the meanings recited in the specification. These compounds are usable in the treatment of diseases of the rheumatoid group and for the prevention of allergically induced diseases.
Patent NO-974206-D0 (NO)
Inventor: BOHLMANN ROLF
IPC: C07J13/00
Filed: 1997-09-12
Abstract: This invention describes the new 17-difluoromethylene-estratrienes of general formula I in which R1 is a hydrogen atom or a C1-C10 alkyl group, R5 is a methyl or ethyl group, and R2 is a hydrogen atom or a C1-C10 alkyl group in  alpha - or  beta -position, R3 is a hydrogen atom or a C1-C10 alkyloxy group in  alpha - or  beta -position, R4 is a hydrogen atom in  alpha - or  beta -position, and A, B, D, E and G each is a hydrogen atom, and optionally at least one of substituent pairs G and R2, R2 and R4, R4 and A, A and R3, B and D, D and E is a double bond.
Patent NO-980238-D0 (NO)
Inventor: BISCHOF MARKUS
IPC: E05D15/00
Filed: 1998-01-19
Abstract: A movable wall has a plurality of movable wall elements mounted in horizontally oriented guide rails. The guide rail which defines the path of the movable wall elements from the parked position into the closed position is laid out in a 90 degree curve in the vicinity of a room opening to be closed so that it brings the closed movable wall elements into alignment. The final movable wall element in the direction of the closing motion is mounted on support and guidance elements. At least the rear support and guidance element of the final wall element in the direction of the closing motion, is mounted on the final movable wall element so that the rear support and guidance element can be moved along the final movable wall element. This rear support and guidance element also has its own drive unit, by which drive unit, during the closing process, the final movable wall element is automatically moved into the closed position in which it is flush with the other movable wall elements. Between the final movable wall element and a closing stop mounted on a wall, no gap remains which would have to be closed by an additional shutter.
Patent NO-991267-D0 (NO)
Inventor: KANAND J RGEN
IPC: C07C43/00
Filed: 1999-03-16
Abstract: In a process for producing n-butylalkyl ethers, (a) 1,3-butadiene or a butadiene-containing hydrocarbon mixture is reacted with an alcohol of formula ROH (I), in which the radical R is a C2-C20 alkyl or alkenyl group substituted or not with 1 to 2 C1-C10 alkoxy or hydroxy groups, a C6-C10 aryl or C7-C11 aralkyl group or a methyl group, at an increased temperature and pressure in the presence of a Brönsted acid or in the presence of a complex of an element of groups Ib, VIIb or VIIIb of the periodic table of elements with a phosphorus- or nitrogen-containing ligand, yielding a mixture of addition products of formulas (II) and (III); (b) the isomers are separated; (c) addition product III is isomerised into addition product II; (d) addition product II is hydrogenated in the presence of a homogeneous or heterogeneous transition metal element catalyst in the liquid phase or in the presence of a heterogeneous, transition metal element-containing catalyst in the gas phase, yielding n-butylalkyl ether of formula (IV).
Patent NO-991742-D0 (NO)
Inventor: KINGSMAN ALAN JOHN
IPC: A61K48/00
Filed: 1999-04-13
Abstract: Retroviral vector particles capable of infecting and transducing non-dividing mammalian target cells, which vector particles may be based on letiviruses such as HIV and which have an RNA genome constructed so as to provide in the DNA provirus a non-lentiviral expression control element in the 5'LTR of the provirus.
Patent NO-994487-D0 (NO)
Inventor: MOLTZEN EJNER K
IPC: C07D491/107
Filed: 1999-09-16
Abstract: Piperidine compounds having the general general Formula Iwherein R<sup>1</sup> isa group having the general Formula II :wherein X is CHR<sup>10</sup>, O, S, SO, SO<sub>2</sub> or NR<sup>10</sup>, R<sup>10</sup> being hydrogen, alkyl or alkenyl, an amino group, sulfonyl, optionally substituted phenyl or a hetero aromatic group; Y is CH, CH<sub>2</sub>, NH, C=O or C=S; R<sup>a</sup> ― R<sup>d</sup> are substituents; U is CH<sub>2</sub>, O or S; Q<sup>1</sup> is a bond , alkylene or alkenylen and Q<sup>2</sup> alkylene having at least two C-atoms or alkenyleneR<sup>2</sup> and R<sup>3</sup> are hydrogen, or alkyl or they may together form an ethylene or propylene bridge; R<sup>4</sup> to R<sup>7</sup> are substituents; andZ<sup>1</sup> is substituent, Z<sup>2</sup> is hydrogen and Z<sup>3</sup> is (CH<sub>2</sub>)<sub>n</sub> wherein n is 0; show potent sigma receptor activity. Furthermore they show effect in animal models indicative of anxiolytic properties. Accordingly they are useful as medicines for the treatment of anxiety, psychosis, epilepsy, convulsion, movement disorders, motor disturbances, amnesia, cerebrovascular diseases, senile dementia of the Alzheimer type or Parkinson's disease.
Patent GB-0001309-D0 (GB)
Title: Valve arrangement
IPC: A61M39/24
Filed: 2000-01-20
Abstract: A valve arrangement is described for providing clinical nutrition. The arrangement comprises a split flushing valve. Also described are a method of production of the valve arrangement, use of the valve arrangement in providing nutrition to a patient and a method of treatment of a patient that comprises administering an effective amount of a composition via the valve arrangement.
Patent GB-0006950-D0 (GB)
Title: Die molding apparatus for resin article
IPC: B29C45/17
Filed: 2000-03-23
Abstract: In a die molding apparatus for molding resin articles having a plurality of molds for forming a cavity in communication with an injection gate and a gas charging nozzle capable of charging the inside of the cavity with a gas after the completion of resin injection to form a resin article having a hollow inside, an overflow portion for relieving an excess molten resin and a film gate for communication between the main cavity portion and the overflow portion are formed between a pair of molds forming the other end of the cavity, and the gap between both of molds is set to 1.5 mm or less at the film gate; the gas charging nozzle is situated in the cavity with a gas charging hole being positioned in the cavity; and a hole-sealed hollow cylinder is formed between one of molds and the gas charging nozzle, the hole-sealed hollow cylinder having an inner surface shape defined by the outer surface of the cylindrical small diameter portion and the step and an outer surface shape defined by the inner surface of the insertion hole of the gas charging nozzle provided the cavity.
Patent GB-0008830-D0 (GB)
Title: Stabiliser for ladders
IPC: E06C7/44
Filed: 2000-04-12
Abstract: A stabiliser for ladders comprises a rigid, generally flat base (10; 71) having a linear channel (11; 70) extending along a first, upper surface thereof, which channel is defined by a pair of generally parallel, upwardly-extending side members having upper edges directed towards each other, and at least one ladder attachment (18, 19; 30, 35; 50, 53) by means of which a ladder stile (17; 66, 67) may be extended downwardly.
Patent GB-0011428-D0 (GB)
Title: Method of forming a fluid tight seal
IPC: F16L13/11
Filed: 2000-05-12
Abstract: A method of forming a fluid tight seal between a first fluid pathway and a second fluid pathway a volume is defined between an outer surface of the first fluid pathway and an inner surface of the second fluid pathway. The surfaces are maintained in a given orientation and distance with respect, one to another, so as to achieve a desired capillaric property therebetween. A quantity of sealant is delivered to a junction region of said surfaces. The sealant is caused or permitted to flow into the defined volume, so as to achieve capillary balance. Only substantially sufficient sealant is delivered to fill the volume. The sealant is then caused or permitted to cure or set.
Patent GB-0118853-D0 (GB)
Title: Road weather prediction system and method
IPC: G01W1/00
Filed: 2001-08-02
Abstract: In one aspect, the present invention relates to a method of determining the sky-view factor at a location. The method comprises the steps of receiving data from at least one global positioning satellite at the location, and comparing the data so obtained with a mathematical function. The function is derived from corresponding data obtained from reference locations at which the sky view factor is known, whereby to arrive at an approximation of the sky view factor at said location. In another aspect, the invention relates to a method for predicting the variation in temperatures over time at locations along a survey route, particularly a road network. The method comprises the steps of establishing a database for the survey route containing location specific geographical parameters, obtaining actual and forecast meteorological data and separately predicting the temperature at each location using energy balance equations. The predicted temperature calculated for each location is dependent upon the meteorological data and the geographical parameters for the location whose temperature is being predicted. The invention also discloses systems which relate to the above methods.